Asperger
syndrome is an
autism spectrum disorder characterized by impaired communication skills and
repetitive thoughts or behavior. Symptoms associated with the Asperger syndrome
are lack of speech recognition skills, dislike for routine changes, avoidance
of eye contacts, unusual facial expressions, and delayed motor development.
Request
to Get Free Sample Pages at:
The
treatment of the disease involves social training skills, medications, and
cognitive behavioral therapy. However, the actual cause of the disease is still
unknown. AgeneBio Inc. is in the process of developing GABAA α5 positive
allosteric modulator for the treatment of Asperger syndrome. GW Pharmaceuticals
plc is in the process of developing GWP42006 as a cannabinoid receptor
modulator for the treatment of this disease.
Access
Detailed Report Summary:
The report
provides a comprehensive understanding of the pipeline activities covering all
drug candidates under various stages of development, with the detailed analysis
of pipeline and clinical trials.
Make
Enquiry Before Buying the Report:
Pipeline
analysis of drugs by phases includes product description and development
activities including information about clinical results, designations,
collaborations, licensing, grants, technology, and others.
No comments:
Post a Comment